Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

NCT01575548 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

129

Enrollment

NIH

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v7

Interventions

PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Pazopanib Hydrochloride
OTHER: Placebo Administration
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)